Biosenic (FRA:BT1) Days Sales Outstanding : 0.00 (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biosenic Days Sales Outstanding?

Biosenic's average Accounts Receivable for the six months ended in Jun. 2023 was €0.55 Mil. Biosenic's Revenue for the six months ended in Jun. 2023 was €0.00 Mil.

The historical rank and industry rank for Biosenic's Days Sales Outstanding or its related term are showing as below:

During the past 10 years, Biosenic's highest Days Sales Outstanding was 267.07. The lowest was 182.14. And the median was 219.55.

FRA:BT1's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 71.92
* Ranked among companies with meaningful Days Sales Outstanding only.

Biosenic's Days Sales Outstanding stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

Biosenic Days Sales Outstanding Historical Data

The historical data trend for Biosenic's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Days Sales Outstanding Chart

Biosenic Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

182.14

219.55

Biosenic Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biosenic's Days Sales Outstanding

For the Biotechnology subindustry, Biosenic's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenic's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biosenic's Days Sales Outstanding falls into.

Biosenic Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biosenic's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0	+	1.036)	/	1 )	/	0	*	365
=	1.036					/	0	*	365
=	N/A

Biosenic's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (1.036	+	0.067)	/	2 )	/	0	*	365 / 2
=	0.5515					/	0	*	365 / 2
=	N/A

Biosenic (FRA:BT1) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biosenic Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biosenic's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosenic (FRA:BT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (FRA:BT1) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BIOS:Belgium

Address

Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435

Website

https://www.biosenic.com

Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic (FRA:BT1) Headlines

No Headlines